• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Difference in stroke incidence between Korean and Japanese patients initiating dialysis — era or ethnic effect?
We thank Tomoyuki Kawada for the letter in response to our recent article [1]. First, we would like to focus on the differences in epidemiologic characteristics of stroke between our study population and those enrolled in a previous study conducted in Japan [2]. As indicated, the main difference in the findings between the two studies was that the proportion of hemorrhagic stroke among the total stroke events was substantially higher in the Japanese study than in our study (52% vs. 21%). Although the definite reasons for this difference remain uncertain, adding to the possible association kindly suggested by Kawada, some s...
Source: International Journal of Cardiology - September 18, 2015 Category: Cardiology Authors: Hyunwook Kim, Dong-Ryeol Ryu Tags: Correspondence Source Type: research

Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke
Kim et al. determined the incidence rates of major adverse cardiac and cerebrovascular events (MACCE) and compared several types of events between hemodialysis (HD) patients and peritoneal dialysis (PD) patients [1]. The authors handled 22,892 HD patients and 7,387 PD patients in Korea by intention-to-treat method, and median follow-up period was 21.5 months. The risk of several cardiac events in PD patients was significantly higher than that in HD patients. In contrast, the incidence rate of non-fatal hemorrhagic stroke in HD patients showed significantly higher than that in PD patients, and there was no significant diffe...
Source: International Journal of Cardiology - September 21, 2015 Category: Cardiology Authors: Tomoyuki Kawada Source Type: research

Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis
With great interest, we read Chen et al. study about antithrombotic agents in patients with end stage renal disease (ESRD) and atrial fibrillation (AF) [1]. The authors found that anti-platelet or warfarin treatment could not lower the risk of ischemic stroke in patients with ESRD. We have some concerns about this study.
Source: International Journal of Cardiology - April 28, 2015 Category: Cardiology Authors: Chin-Wei Hsu, Yaw-Bin Huang, Chung-Yu Chen Tags: Letter to the Editor Source Type: research

Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender
We have read with great interest the article by Guo and colleagues concerning renal dysfunction (defined as the presence of chronic dialysis, renal transplantation or an estimated glomerular filtration rate, eGFR,
Source: International Journal of Cardiology - May 3, 2013 Category: Cardiology Authors: Rui Providência, Sérgio Barra, Luís Paiva Tags: Letters to the Editor Source Type: research

Impact Of Moderate Preoperative Chronic Kidney Disease On Mortality After Transcatheter Aortic Valve Implantation
Preoperative chronic kidney disease (CKD) has been found as an important determinant of clinical outcomes following transcatheter aortic valve implantation (TAVI) [1]. In a recent meta-analysis including 4992 TAVI patients, we demonstrated that CKD (stages 3-5) significantly increases early (30-day) and 1-year all-cause mortality, cardiovascular mortality, early stroke, acute kidney injury (AKI and AKI stages 2-3), need for dialysis, and length of hospitalization [1]. Intriguingly, even moderate CKD (stage 3) was found to be associated to worse outcomes after TAVI, in opposition to previous studies [2,3].
Source: International Journal of Cardiology - April 10, 2015 Category: Cardiology Authors: Giuseppe Gargiulo, Davide Capodanno, Anna Sannino, Cinzia Perrino, Piera Capranzano, Eugenio Stabile, Bruno Trimarco, Corrado Tamburino, Giovanni Esposito Tags: Letters to the Editor Source Type: research

Difference in stroke incidence between Korean and Japanese patients initiating dialysis – Era or Ethnic effect?
Source: International Journal of Cardiology - September 18, 2015 Category: Cardiology Authors: Hyunwook Kim, Dong-Ryeol Ryu Source Type: research

‘Some doors are better left closed’: Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation
Since 2011, when the EMA approved the treatment with novel oral anticoagulants (NOACs) for primary prevention of cardio-embolic stroke in patients with atrial fibrillation (AF), a reasonable question repeatedly arose: “Will NOACs become the new standard of care in anticoagulation therapy?” [1]. While for many cathegories of patients the answer soon become positive [2], the sub-group of advanced chronic kidney disease (CKD) 5D stage (in dialysis) has never received a “yes” from either FDA or EMA (none of t hem allowing the use of NOACs in 5D CKD).
Source: International Journal of Cardiology - April 27, 2018 Category: Cardiology Authors: Alexandru Burlacu, Adrian Covic Tags: Editorial Source Type: research